MeSH D015210 - gouty arthritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Indomethacin | Indo-lemmon |  | 1985-11-07 |  |  |
| Indomethacin | Indomethacin |  | 1988-04-18 |  |  | |
| Phenylbutazone | Phenylbutazone |  | 1983-06-24 |  |  | |
| Novast Laboratories | Indomethacin | Indomethacin |  | 2017-05-08 |  |  |
| Glenmark Pharmaceuticals | Indomethacin | Indomethacin |  | 2010-12-22 |  |  |
| Mylan | Febuxostat | Febuxostat Mylan |  | 2017-06-15 |  |  |
| Indomethacin | Indomethacin |  | 2014-03-20 |  |  | |
| Sandoz | Indomethacin | Indomethacin |  | 1987-04-29 |  |  |
| Novartis | Phenylbutazone | Butazolidin |  | 1982-01-01 |  |  |
| Canakinumab | Ilaris |  | 2009-10-23 | $1,206 M | Q2/21-Q2/24 | |
| Sanofi | Phenylbutazone | Azolid |  | 1982-01-01 |  |  |
| Genus Lifesciences | Indomethacin | Tivorbex | 2030-04-23 | 2014-02-24 |  |  |
| Pfizer | Indomethacin | Indomethacin |  | 1984-11-23 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
22%2/9
Phase 3
78%7/9
Approved: 5Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use